Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  _______________ FORM 8-K  _______________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report:  May 22, 2025 (Date of earliest event reported)  _______________ TENET HEALTHCARE CORP ORATION (Exact name of registrant as specified in its charter)   Nevada   1-7293   95-2557091 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number)  _______________ 14201 Dallas Parkway Dallas , TX   75254 (Address of principal executive offices, including zip code) ( 469 ) 893-2200 (Registrant’s telephone number, including area code)  _______________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.05 par value THC NYSE 6.875% Senior Notes due 2031 THC31 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).     Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07. Submission of Matters to a Vote of Security Holders. The 2025 Annual Meeting of Shareholders (the “Annual Meeting”) of Tenet Healthcare Corporation (the “Company”) was held on May 22, 2025 . Below are the final voting results from the meeting. 1.    The Company’s shareholders elected the following directors to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Saumya Sutaria 75,129,573  3,175,124  41,625  7,527,011  J. Robert Kerrey 76,518,701  1,792,925  34,696  7,527,011  Vineeta Agarwala 78,006,611  308,065  31,646  7,527,011  James L. Bierman 77,926,307  387,722  32,293  7,527,011  Roy Blunt 77,882,738  431,663  31,921  7,527,011  Richard W. Fisher 77,904,115  409,618  32,589  7,527,011  Meghan M. FitzGerald 77,624,893  691,419  30,010  7,527,011  Cecil D. Haney 77,887,930  401,532  56,860  7,527,011  Christopher S. Lynch 77,995,490  318,301  32,531  7,527,011  Richard J. Mark 77,978,174  334,968  33,180  7,527,011  Tammy Romo 75,980,163  2,335,099  31,060  7,527,011  Stephen H. Rusckowski 77,992,021  321,640  32,661  7,527,011  Nadja Y. West 77,762,668  529,830  53,824  7,527,011  2.    The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation: FOR AGAINST ABSTAIN BROKER NON-VOTES 72,929,010 5,362,708 54,604 7,527,011  3.     The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2025: FOR AGAINST ABSTAIN BROKER NON-VOTES 85,288,950 538,057 46,326 — 4.     The shareholder proposal requesting a report on strategies and programs for improving maternal health outcomes did not pass. FOR AGAINST ABSTAIN BROKER NON-VOTES 3,845,664 73,121,521 1,379,137 7,527,011 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: May 27, 2025 By: /s/ T HOMAS A RNST Name: Thomas Arnst Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary